Charles Schwab Investment Management Inc Amgen Inc Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,205,942 shares of AMGN stock, worth $3.4 Billion. This represents 0.73% of its overall portfolio holdings.
Number of Shares
12,205,942
Previous 13,205,604
7.57%
Holding current value
$3.4 Billion
Previous $3.44 Billion
10.48%
% of portfolio
0.73%
Previous 0.65%
Shares
31 transactions
Others Institutions Holding AMGN
# of Institutions
3,309Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.12 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.65 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.52 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $149B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...